1. Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up. (1st December 2021) Authors: Papp, K.A.; Lebwohl, M.G.; Puig, L.; Ohtsuki, M.; Beissert, S.; Zeng, J.; Rubant, S.; Sinvhal, R.; Zhao, Y.; Soliman, A.M.; Alperovich, G.; Leonardi, C. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up. (21st September 2021) Authors: Papp, K.A.; Lebwohl, M.G.; Puig, L.; Ohtsuki, M.; Beissert, S.; Zeng, J.; Rubant, S.; Sinvhal, R.; Zhao, Y.; Soliman, A.M.; Alperovich, G.; Leonardi, C. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term safety of risankizumab from 17 clinical trials in patients with moderate‐to‐severe plaque psoriasis. (1st March 2022) Authors: Gordon, K.B.; Lebwohl, M.; Papp, K.A.; Bachelez, H.; Wu, J.J.; Langley, R.G.; Blauvelt, A.; Kaplan, B.; Shah, M.; Zhao, Y.; Sinvhal, R.; Reich, K. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long‐term safety of risankizumab from 17 clinical trials in patients with moderate‐to‐severe plaque psoriasis. (24th November 2021) Authors: Gordon, K.B.; Lebwohl, M.; Papp, K.A.; Bachelez, H.; Wu, J.J.; Langley, R.G.; Blauvelt, A.; Kaplan, B.; Shah, M.; Zhao, Y.; Sinvhal, R.; Reich, K. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗